Cabello-Ubeda A, Lopez Bernardo de Quiros JC, Mena A, Torralba M, et al. Dolutegravir (DTG) + lamivudine (3TC) in antiretroviral-naive adults with HIV with and without genotypic resistance testing results. 96-Week effectiveness and tolerability of REDOLA study. J Acquir Immune Defic Syndr 2025 Jul 17. doi: 10.1097/QAI.0000000000003721.
PMID: 40673705